Introducing Spotlight Series from theAmerican Heart Association


Complimentary CME/CE programs on the newest, evidence-based
measures to prevent cardiovascular disease.

About Spotlight Series


Complimentary CME/CE presentations delivered
by American Heart Association experts at hospital grand rounds, nationwide.


Heart disease is the number one killer of men and women in the United States, and nearly 70% of the population, over 60 years of age, are personally affected by cardiovascular disease. Educating healthcare professionals on the latest science, and current guideline recommendations can help to improve patient care and promote better outcomes.

 

The American Heart Association promises to be the most trusted provider of quality and relevant professional education by delivering best practice and emerging scientific knowledge to healthcare professionals and resources to translate that knowledge for the prevention, diagnosis and treatment of cardiovascular disease and stroke.

 

Spotlight Series, which began in 2008, offers free, case-based presentations designed to educate healthcare providers on evidence-based practices. The target audience includes internists, family practice physicians and other primary care physicians, cardiologists, nurses, pharmacists, physician assistants and other clinicians involved in the treatment of patients with or at risk for cardiovascular disease. The AHA is the accredited provider for this program and CME/CE credit is available to all physician, nurse and pharmacist attendees.

By incorporating Spotlight Series presentations into your institution's educational programming, together we can help build healthier lives, free of cardiovascular diseases and stroke.


Why Request a Spotlight Series?

IT'S FREE! There is no cost to your institution.


LIVE
PRESENTATIONS


AHA-Approved
Content


CME/CE
credit


Delivered
By AHA Experts

Did we mention IT'S FREE?

Available Series

Please select a series below to view more information

Stroke Work-up: Atrial Fibrillation

Atrial Fibrillation (AF) is a leading cause of cryptogenic stroke but is underdiagnosed and undertreated. Participants will be educated on the prevalence of AF with cryptogenic stroke and identification of cardiac monitoring modalities including opportunities to improve its diagnosis to prevent a stroke recurrence. Learn how you can improve your patient's outcomes. For more information please visit Stroke Work-up: Atrial Fibrillation.

This activity is supported by an independent medical educational grant from Medtronic.

Request This Topic

Reducing Readmission after Heart Failure: An Evidence Based Approach

Data from the CDC states that about 5.1 million people in the US have heart failure. Data from the Centers for Medicare & Medicaid Services state the US national average readmission rate for HF patients is now 23%. The readmission rate for HF patients is indisputably high; in part, because HF is an extraordinarily complex disease and the underlying reasons for readmissions in HF patients encompass a host of factors. Learn how you can impact the hospital readmission rate for heart failure patients. For more information please visit Reducing Readmission after Heart Failure: An Evidence Based Approach.

This activity is supported by independent medical educational grants from Amgen, Inc. and Novartis.

**REQUESTS FOR A LIVE PRESENTATION AT YOUR INSTITUTION ARE NO LONGER BEING ACCEPTED**

Request This Topic


Request This Topic


Series in Development:


  • Anticoagulants and Antithrombotic Controversies for Stroke Prevention in Atrial Fibrillation

Contact Us

Your feedback is important to us. For all inquiries, comments, and suggestions regarding the Spotlight Series, please complete the form below.

Send us a Message
 
Other Methods
  • Address:
    7272 Greenville Ave.
    Dallas, TX 75231
  • Phone number:
    1-888-242-2453
  • E-mail:
    AHAspotlightseries@heart.org